Accessibility Statement Skip Navigation
  • Resources
  • Investor Relations
  • Journalists
  • Agencies
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • All Public Company
      • English-only
      • News Releases Overview

      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
      • Multimedia Gallery Overview

      • Trending Topics

      • All Trending Topics
  • Business & Money
      • Auto & Transportation

      • All Automotive & Transportation
      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • Auto & Transportation Overview

      • View All Auto & Transportation

      • Business Technology

      • All Business Technology
      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • Business Technology Overview

      • View All Business Technology

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Financial Services & Investing

      • All Financial Services & Investing
      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • Financial Services & Investing Overview

      • View All Financial Services & Investing

      • General Business

      • All General Business
      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • General Business Overview

      • View All General Business

  • Science & Tech
      • Consumer Technology

      • All Consumer Technology
      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • Consumer Technology Overview

      • View All Consumer Technology

      • Energy & Natural Resources

      • All Energy
      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • Energy & Natural Resources Overview

      • View All Energy & Natural Resources

      • Environ­ment

      • All Environ­ment
      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • Environ­ment Overview

      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • All Heavy Industry & Manufacturing
      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • Heavy Industry & Manufacturing Overview

      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • All Telecomm­unications
      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • Telecomm­unications Overview

      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • All Consumer Products & Retail
      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • Consumer Products & Retail Overview

      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Health

      • All Health
      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • Health Overview

      • View All Health

      • Sports

      • All Sports
      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • Sports Overview

      • View All Sports

      • Travel

      • All Travel
      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • Travel Overview

      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • All Policy & Public Interest
      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • Policy & Public Interest Overview

      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • All People & Culture
      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • People & Culture Overview

      • View All People & Culture

      • In-Language News

      • Arabic
      • español
      • português
      • Česko
      • Danmark
      • Deutschland
      • España
      • France
      • Italia
      • Nederland
      • Norge
      • Polska
      • Portugal
      • Россия
      • Slovensko
      • Suomi
      • Sverige
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Amplify Content
  • All Products
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • Hamburger menu
  • PR Newswire: news distribution, targeting and monitoring
  • Send a Release
    • ALL CONTACT INFO
    • Contact Us

      888-776-0942
      from 8 AM - 10 PM ET

  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • News in Focus
    • Browse All News
    • Multimedia Gallery
    • Trending Topics
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Amplify Content
  • All Products
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS

Veterinary Dermatology Drugs Market is projected to reach US$ 9.9 Bn by 2031, Increase in Inclination toward Preventive Healthcare and Use of Antifungal Medicines to Drive the Market, notes TMR Study

- Many countries are spending on veterinary medications in order to increase the productivity of farm animals

- Improved diagnostics, rise in awareness on preventive healthcare and overall well-being, and improved nutrition are contributing to the rise in the usage of veterinary dermatological medications

TMR Logo

News provided by

Transparency Market Research

Dec 07, 2021, 08:30 ET

Share this article

Share toX

Share this article

Share toX

ALBANY, N.Y., Dec. 7, 2021 /PRNewswire/ -- Illnesses such as protozoal parasitic and helminth parasites diseases are becoming more prevalent. The global veterinary dermatology drugs market is estimated to grow due to the introduction of better technologies, such as molecular diagnostics, for early detection and treatment of these illnesses.

Variations in clinical manifestations, such as the disease stage, hereditary factors, size of lesions, secondary infections, and climatic circumstances can make a precise diagnosis of the disease difficult. Itching is frequent in companion animals, and the most common cause is atopic dermatitis. Atopy is a hereditary predisposition to allergic illnesses such as atopic dermatitis (eczema), asthma, and allergic rhinitis. Atopic dermatitis is the most prevalent reason for rubbing, gnawing, biting, or ear infections in domestic pets such as dogs and cats. It causes other chronic illnesses in domestic pets as well.

Request Brochure of Veterinary Dermatology Drugs Market Research Report - https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=61659 

Dermatophytes cause a number of zoonotic diseases, and they are thought to be responsible for around 80% of human skin disorders transmitted through animals. Recent advancements in animal drugs and therapies, on the other hand, have shown to be effective in the treatment of such disorders. In addition, producers are centering their efforts on research and development in order to avert dermatophytes and maladies associated with them. These advancements are expected to draw a number of pet owners toward the use of veterinary dermatology drugs, which is likely to boost the market during the forecast period.

The global veterinary dermatology drugs market was valued at more than US$ 3.6 Bn in 2020, and is estimated to rise at a moderate CAGR during the forecast period from 2021 to 2031.

Request for Analysis of COVID-19 Impact on Veterinary Dermatology Drugs Market – https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=61659

Key Findings of Market Report

  • Rise in Adoption of Pets and Concerns over Animal Well-being to Drive Global Market

Due to the growing knowledge of veterinary care, the global veterinary dermatology drugs market has witnessed significant rise in the past few years. The market is expected to develop in response to growing urbanization and increase in the number of companion animals. The increasing prevalence of atopic dermatitis in animals necessitates the development of more effective veterinary medicines. People, particularly pet guardians and owners, are learning about veterinarian skin problems, treatment alternatives, and different government programs to boost the productivity of farm animals. Additionally, the global market is expected to grow due to an increase in the number of companion animals and the willingness of pet owners to pay for their care.

  • Increase in Demand for Antifungal Medicines to Treat Dermatological Conditions in Animals

Antifungal medicines are now utilized to treat skin disorders in animals. Although griseofulvin is the only antifungal that the Food and Drug Administration (FDA) recommends for systemic therapy in veterinary medicine, a range of systemic antifungals are also available. The growth of generic formulations has resulted in a plethora of cost-effective pharmaceuticals in the market today. The production of newer antifungals such as voriconazole, fluconazole, itraconazole, and posaconazole has been affected by the formation of immunity in fungal organisms. The global veterinary dermatology drugs market is estimated be driven by effective and better treatment options in the forthcoming years.

TMR offers custom market research services that help clients to get information on their business scenario required where syndicated solutions are not enough, Request for Custom Research - https://www.transparencymarketresearch.com/sample/sample.php?flag=CR&rep_id=61659

Veterinary Dermatology Drugs Market: Growth Drivers

  • Due to increasing incidence of pustules, seborrhea, scales, eruptions, masses, sores, alopecia, and draining tracts in animals, North America is likely to account for a prominent share of the veterinary dermatology drugs market during the forecast period
  • Improvements in medical as well as diagnostic treatments for companion animals as well as increase in pet ownership are expected to benefit the global veterinary dermatology drugs market

Buy Veterinary Dermatology Drugs Market Report – https://www.transparencymarketresearch.com/checkout.php?rep_id=61659&ltype=S 

Veterinary Dermatology Drugs Market: Key Competitors

Some of the key market players are

  • Novartis Animal Health
  • Ceva Sante Animale
  • Bayer Animal Health
  • Boehringer Ingelheim Group
  • IDEXX Laboratories
  • AB Science SA

Veterinary Dermatology Drugs Market: Segmentation

Product Type

  • Antifungal Drugs
  • Antibacterial Drugs
  • Antiparasitic Drugs

Mode of Administration

  • Topical
  • Oral
  • Injectable

Type of Animal

  • Large Animals
  • Small Animals

Indication

  • Infectious Diseases
  • Skin Cancer
  • Autoimmune Skin Diseases
  • Parasitic Infections

Modernization of healthcare in terms of both infrastructure and services have pushed the healthcare industry to new heights, Stay Updated with Latest Healthcare Industry Research Reports by Transparency Market Research:

Veterinary Lasers Market: The report offers information about the dynamics, segmentation, and competitive landscape. The report offers insights over the revenue and predicts growth prospects in upcoming years. Most importantly, the report offers the competitive vendor landscape which offers in-depth information about the strategies that the key players have adopted in order to gain substantial shares in the global market for veterinary lasers.

Orthopedic Veterinary Implants Market: The global orthopedic veterinary implants market is relatively new and hence it is not a tightly regulated one. So far, FDA approvals are not needed for new products in the market. This has egged regional players to foray into the space with affordable implants. In fact, products manufactured by small scale companies, which are almost 10% to 15% cheaper than those produced by large, well-entrenched companies are seeing swift uptake in the global orthopedic veterinary implants market.

Veterinary CT scanner Market: A veterinary CT scanner is used to obtain high-resolution three-dimensional anatomical diagnostic images of animals. It allows for expedient and dynamic care of animals. Veterinary CT scanners are more convenient and beneficial in comparison to conventional imaging devices such as ultrasound systems and x- rays as they provide comprehensive data for better diagnosis and treatment while reducing the need for investigative surgeries. 

About Us

Transparency Market Research is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants, use proprietary data sources and various tools and techniques to gather, and analyze information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

For More Research Insights on Leading Industries, Visit Our YouTube Channel and hit subscribe for Future Update - https://www.youtube.com/channel/UC8e-z-g23-TdDMuODiL8BKQ

Contact
Mr. Rohit Bhisey
Transparency Market Research
State Tower,
90 State Street,
Suite 700,
Albany NY – 12207
United States
USA - Canada Toll Free: 866-552-3453
Email: [email protected]
Follow Us: Twitter | LinkedIn
Blog: https://tmrblog.com
Browse PR - https://www.transparencymarketresearch.com/pressrelease/veterinary-dermatology-drugs-market.htm 

SOURCE Transparency Market Research

WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?

icon3
440k+
Newsrooms &
Influencers
icon1
9k+
Digital Media
Outlets
icon2
270k+
Journalists
Opted In
GET STARTED

Modal title

Contact PR Newswire

  • Call PR Newswire at 888-776-0942
    from 8 AM - 9 PM ET
  • Chat with an Expert
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices

Products

  • For Marketers
  • For Public Relations
  • For IR & Compliance
  • For Agency
  • All Products

About

  • About PR Newswire
  • About Cision
  • Become a Publishing Partner
  • Become a Channel Partner
  • Careers
  • Accessibility Statement
  • APAC
  • APAC - Simplified Chinese
  • APAC - Traditional Chinese
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Indonesia
  • Israel
  • Italy
  • Japan
  • Korea
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United Kingdom
  • Vietnam

My Services

  • All New Releases
  • Platform Login
  • ProfNet
  • Data Privacy

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact PR Newswire

Products

About

My Services
  • All News Releases
  • Platform Login
  • ProfNet
Call PR Newswire at
888-776-0942
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • RSS
  • Cookies
Copyright © 2025 Cision US Inc.